IBDEI060 ; ; 09-FEB-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,8026,1,2,0)
 ;;=2^729.2
 ;;^UTILITY(U,$J,358.3,8026,1,5,0)
 ;;=5^RADICULOPATHY
 ;;^UTILITY(U,$J,358.3,8026,2)
 ;;=^82605
 ;;^UTILITY(U,$J,358.3,8027,0)
 ;;=782.1^^50^566^2
 ;;^UTILITY(U,$J,358.3,8027,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8027,1,2,0)
 ;;=2^782.1
 ;;^UTILITY(U,$J,358.3,8027,1,5,0)
 ;;=5^RASH
 ;;^UTILITY(U,$J,358.3,8027,2)
 ;;=^102948
 ;;^UTILITY(U,$J,358.3,8028,0)
 ;;=569.3^^50^566^3
 ;;^UTILITY(U,$J,358.3,8028,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8028,1,2,0)
 ;;=2^569.3
 ;;^UTILITY(U,$J,358.3,8028,1,5,0)
 ;;=5^RECTAL BLEEDING
 ;;^UTILITY(U,$J,358.3,8028,2)
 ;;=^55914
 ;;^UTILITY(U,$J,358.3,8029,0)
 ;;=592.0^^50^566^4
 ;;^UTILITY(U,$J,358.3,8029,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8029,1,2,0)
 ;;=2^592.0
 ;;^UTILITY(U,$J,358.3,8029,1,5,0)
 ;;=5^RENAL CALCULI
 ;;^UTILITY(U,$J,358.3,8029,2)
 ;;=^67056
 ;;^UTILITY(U,$J,358.3,8030,0)
 ;;=585.9^^50^566^6
 ;;^UTILITY(U,$J,358.3,8030,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8030,1,2,0)
 ;;=2^585.9
 ;;^UTILITY(U,$J,358.3,8030,1,5,0)
 ;;=5^RENAL FAILURE,CHRONIC
 ;;^UTILITY(U,$J,358.3,8030,2)
 ;;=^332812
 ;;^UTILITY(U,$J,358.3,8031,0)
 ;;=584.9^^50^566^5
 ;;^UTILITY(U,$J,358.3,8031,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8031,1,2,0)
 ;;=2^584.9
 ;;^UTILITY(U,$J,358.3,8031,1,5,0)
 ;;=5^RENAL FAILURE,ACUTE
 ;;^UTILITY(U,$J,358.3,8031,2)
 ;;=^338532
 ;;^UTILITY(U,$J,358.3,8032,0)
 ;;=714.0^^50^566^8
 ;;^UTILITY(U,$J,358.3,8032,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8032,1,2,0)
 ;;=2^714.0
 ;;^UTILITY(U,$J,358.3,8032,1,5,0)
 ;;=5^RHEUMATOID ARTHRITIS
 ;;^UTILITY(U,$J,358.3,8032,2)
 ;;=^10473
 ;;^UTILITY(U,$J,358.3,8033,0)
 ;;=460.^^50^566^9
 ;;^UTILITY(U,$J,358.3,8033,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8033,1,2,0)
 ;;=2^460.
 ;;^UTILITY(U,$J,358.3,8033,1,5,0)
 ;;=5^RHINITIS,ACUTE
 ;;^UTILITY(U,$J,358.3,8033,2)
 ;;=^26543
 ;;^UTILITY(U,$J,358.3,8034,0)
 ;;=472.0^^50^566^10
 ;;^UTILITY(U,$J,358.3,8034,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8034,1,2,0)
 ;;=2^472.0
 ;;^UTILITY(U,$J,358.3,8034,1,5,0)
 ;;=5^RHINITIS,CHRONIC
 ;;^UTILITY(U,$J,358.3,8034,2)
 ;;=^24434
 ;;^UTILITY(U,$J,358.3,8035,0)
 ;;=593.9^^50^566^7
 ;;^UTILITY(U,$J,358.3,8035,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8035,1,2,0)
 ;;=2^593.9
 ;;^UTILITY(U,$J,358.3,8035,1,5,0)
 ;;=5^RENAL INSUFFICIENCY
 ;;^UTILITY(U,$J,358.3,8035,2)
 ;;=^123849
 ;;^UTILITY(U,$J,358.3,8036,0)
 ;;=726.90^^50^567^1
 ;;^UTILITY(U,$J,358.3,8036,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8036,1,2,0)
 ;;=2^726.90
 ;;^UTILITY(U,$J,358.3,8036,1,5,0)
 ;;=5^TENDONITIS
 ;;^UTILITY(U,$J,358.3,8036,2)
 ;;=^41010
 ;;^UTILITY(U,$J,358.3,8037,0)
 ;;=451.19^^50^567^2
 ;;^UTILITY(U,$J,358.3,8037,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8037,1,2,0)
 ;;=2^451.19
 ;;^UTILITY(U,$J,358.3,8037,1,5,0)
 ;;=5^THROMBOSIS/DVT
 ;;^UTILITY(U,$J,358.3,8037,2)
 ;;=^269812
 ;;^UTILITY(U,$J,358.3,8038,0)
 ;;=110.3^^50^567^3
 ;;^UTILITY(U,$J,358.3,8038,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8038,1,2,0)
 ;;=2^110.3
 ;;^UTILITY(U,$J,358.3,8038,1,5,0)
 ;;=5^TINEA CRURIS
 ;;^UTILITY(U,$J,358.3,8038,2)
 ;;=^33171
 ;;^UTILITY(U,$J,358.3,8039,0)
 ;;=110.4^^50^567^4
 ;;^UTILITY(U,$J,358.3,8039,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8039,1,2,0)
 ;;=2^110.4
 ;;^UTILITY(U,$J,358.3,8039,1,5,0)
 ;;=5^TINEA PEDIS
 ;;^UTILITY(U,$J,358.3,8039,2)
 ;;=^33168
 ;;^UTILITY(U,$J,358.3,8040,0)
 ;;=525.9^^50^567^5
 ;;^UTILITY(U,$J,358.3,8040,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8040,1,2,0)
 ;;=2^525.9
 ;;^UTILITY(U,$J,358.3,8040,1,5,0)
 ;;=5^TOOTHACHE
 ;;^UTILITY(U,$J,358.3,8040,2)
 ;;=^123871
 ;;^UTILITY(U,$J,358.3,8041,0)
 ;;=465.9^^50^567^12
 ;;^UTILITY(U,$J,358.3,8041,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8041,1,2,0)
 ;;=2^465.9
 ;;^UTILITY(U,$J,358.3,8041,1,5,0)
 ;;=5^URI,ACUTE
 ;;^UTILITY(U,$J,358.3,8041,2)
 ;;=^269878
 ;;^UTILITY(U,$J,358.3,8042,0)
 ;;=599.0^^50^567^16
 ;;^UTILITY(U,$J,358.3,8042,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8042,1,2,0)
 ;;=2^599.0
 ;;^UTILITY(U,$J,358.3,8042,1,5,0)
 ;;=5^UTI
 ;;^UTILITY(U,$J,358.3,8042,2)
 ;;=^124436
 ;;^UTILITY(U,$J,358.3,8043,0)
 ;;=597.80^^50^567^11
 ;;^UTILITY(U,$J,358.3,8043,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8043,1,2,0)
 ;;=2^597.80
 ;;^UTILITY(U,$J,358.3,8043,1,5,0)
 ;;=5^URETHRITIS NOS
 ;;^UTILITY(U,$J,358.3,8043,2)
 ;;=^124214
 ;;^UTILITY(U,$J,358.3,8044,0)
 ;;=788.41^^50^567^13
 ;;^UTILITY(U,$J,358.3,8044,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8044,1,2,0)
 ;;=2^788.41
 ;;^UTILITY(U,$J,358.3,8044,1,5,0)
 ;;=5^URINARY FREQUENCY
 ;;^UTILITY(U,$J,358.3,8044,2)
 ;;=^124396
 ;;^UTILITY(U,$J,358.3,8045,0)
 ;;=788.30^^50^567^14
 ;;^UTILITY(U,$J,358.3,8045,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8045,1,2,0)
 ;;=2^788.30
 ;;^UTILITY(U,$J,358.3,8045,1,5,0)
 ;;=5^URINARY INCONTINENCE, UNSPEC
 ;;^UTILITY(U,$J,358.3,8045,2)
 ;;=^124400
 ;;^UTILITY(U,$J,358.3,8046,0)
 ;;=788.20^^50^567^15
 ;;^UTILITY(U,$J,358.3,8046,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8046,1,2,0)
 ;;=2^788.20
 ;;^UTILITY(U,$J,358.3,8046,1,5,0)
 ;;=5^URINARY RETENTION
 ;;^UTILITY(U,$J,358.3,8046,2)
 ;;=^295812
 ;;^UTILITY(U,$J,358.3,8047,0)
 ;;=532.90^^50^567^6
 ;;^UTILITY(U,$J,358.3,8047,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8047,1,2,0)
 ;;=2^532.90
 ;;^UTILITY(U,$J,358.3,8047,1,5,0)
 ;;=5^ULCER,DUODENAL
 ;;^UTILITY(U,$J,358.3,8047,2)
 ;;=^37311
 ;;^UTILITY(U,$J,358.3,8048,0)
 ;;=531.90^^50^567^7
 ;;^UTILITY(U,$J,358.3,8048,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8048,1,2,0)
 ;;=2^531.90
 ;;^UTILITY(U,$J,358.3,8048,1,5,0)
 ;;=5^ULCER,GASTRIC
 ;;^UTILITY(U,$J,358.3,8048,2)
 ;;=^51128
 ;;^UTILITY(U,$J,358.3,8049,0)
 ;;=533.90^^50^567^9
 ;;^UTILITY(U,$J,358.3,8049,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8049,1,2,0)
 ;;=2^533.90
 ;;^UTILITY(U,$J,358.3,8049,1,5,0)
 ;;=5^ULCER,PEPTIC
 ;;^UTILITY(U,$J,358.3,8049,2)
 ;;=^93051
 ;;^UTILITY(U,$J,358.3,8050,0)
 ;;=707.10^^50^567^8
 ;;^UTILITY(U,$J,358.3,8050,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8050,1,2,0)
 ;;=2^707.10
 ;;^UTILITY(U,$J,358.3,8050,1,5,0)
 ;;=5^ULCER,LOWER LIMB
 ;;^UTILITY(U,$J,358.3,8050,2)
 ;;=^322142
 ;;^UTILITY(U,$J,358.3,8051,0)
 ;;=707.9^^50^567^10
 ;;^UTILITY(U,$J,358.3,8051,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8051,1,2,0)
 ;;=2^707.9
 ;;^UTILITY(U,$J,358.3,8051,1,5,0)
 ;;=5^ULCER,SKIN NOS
 ;;^UTILITY(U,$J,358.3,8051,2)
 ;;=^24439
 ;;^UTILITY(U,$J,358.3,8052,0)
 ;;=Q3014^^51^568^1^^^^1
 ;;^UTILITY(U,$J,358.3,8052,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,8052,1,2,0)
 ;;=2^Q3014
 ;;^UTILITY(U,$J,358.3,8052,1,3,0)
 ;;=3^Telehealth Fac Fee-Pt Site
 ;;^UTILITY(U,$J,358.3,8053,0)
 ;;=Q3014^^52^569^5^^^^1
 ;;^UTILITY(U,$J,358.3,8053,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,8053,1,2,0)
 ;;=2^Q3014
 ;;^UTILITY(U,$J,358.3,8053,1,3,0)
 ;;=3^TELEHEALTH FACILITY FEE
 ;;^UTILITY(U,$J,358.3,8054,0)
 ;;=92227^^52^569^3^^^^1
 ;;^UTILITY(U,$J,358.3,8054,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,8054,1,2,0)
 ;;=2^92227
 ;;^UTILITY(U,$J,358.3,8054,1,3,0)
 ;;=3^REMOTE DX RETINAL IMAGING
 ;;^UTILITY(U,$J,358.3,8055,0)
 ;;=92228^^52^569^4^^^^1
 ;;^UTILITY(U,$J,358.3,8055,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,8055,1,2,0)
 ;;=2^92228
 ;;^UTILITY(U,$J,358.3,8055,1,3,0)
 ;;=3^REMOTE IMAGING-RETINAL MGMT
 ;;^UTILITY(U,$J,358.3,8056,0)
 ;;=92250^^52^569^1^^^^1
 ;;^UTILITY(U,$J,358.3,8056,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,8056,1,2,0)
 ;;=2^92250
 ;;^UTILITY(U,$J,358.3,8056,1,3,0)
 ;;=3^FUNDUS PHOTO W/ INTERP & RPT
 ;;^UTILITY(U,$J,358.3,8057,0)
 ;;=T1014^^52^569^6^^^^1
 ;;^UTILITY(U,$J,358.3,8057,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,8057,1,2,0)
 ;;=2^T1014
 ;;^UTILITY(U,$J,358.3,8057,1,3,0)
 ;;=3^TELEHEALTH TRANSMIT, PER MIN
 ;;^UTILITY(U,$J,358.3,8058,0)
 ;;=3072F^^52^569^2^^^^1
 ;;^UTILITY(U,$J,358.3,8058,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,8058,1,2,0)
 ;;=2^3072F
 ;;^UTILITY(U,$J,358.3,8058,1,3,0)
 ;;=3^LOW RISK FOR RETINOPATHY
 ;;^UTILITY(U,$J,358.3,8059,0)
 ;;=373.32^^53^570^48
 ;;^UTILITY(U,$J,358.3,8059,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8059,1,3,0)
 ;;=3^Eyelid,Dermatitis,Allergic
 ;;^UTILITY(U,$J,358.3,8059,1,4,0)
 ;;=4^373.32
 ;;^UTILITY(U,$J,358.3,8059,2)
 ;;=^269061
 ;;^UTILITY(U,$J,358.3,8060,0)
 ;;=373.00^^53^570^4
 ;;^UTILITY(U,$J,358.3,8060,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8060,1,3,0)
 ;;=3^Blepharitis
 ;;^UTILITY(U,$J,358.3,8060,1,4,0)
 ;;=4^373.00
 ;;^UTILITY(U,$J,358.3,8060,2)
 ;;=Blepharitis^15271
 ;;^UTILITY(U,$J,358.3,8061,0)
 ;;=373.2^^53^570^7
 ;;^UTILITY(U,$J,358.3,8061,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8061,1,3,0)
 ;;=3^Chalazion
 ;;^UTILITY(U,$J,358.3,8061,1,4,0)
 ;;=4^373.2
 ;;^UTILITY(U,$J,358.3,8061,2)
 ;;=^22156
 ;;^UTILITY(U,$J,358.3,8062,0)
 ;;=374.84^^53^570^29
 ;;^UTILITY(U,$J,358.3,8062,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8062,1,3,0)
 ;;=3^Eyelid Cysts
 ;;^UTILITY(U,$J,358.3,8062,1,4,0)
 ;;=4^374.84
 ;;^UTILITY(U,$J,358.3,8062,2)
 ;;=^269119
 ;;^UTILITY(U,$J,358.3,8063,0)
 ;;=374.87^^53^570^31
 ;;^UTILITY(U,$J,358.3,8063,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8063,1,3,0)
 ;;=3^Eyelid Dermatochalasis
 ;;^UTILITY(U,$J,358.3,8063,1,4,0)
 ;;=4^374.87
 ;;^UTILITY(U,$J,358.3,8063,2)
 ;;=^269123
 ;;^UTILITY(U,$J,358.3,8064,0)
 ;;=375.15^^53^570^12
 ;;^UTILITY(U,$J,358.3,8064,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8064,1,3,0)
 ;;=3^Dry Eye Syndrome
 ;;^UTILITY(U,$J,358.3,8064,1,4,0)
 ;;=4^375.15
 ;;^UTILITY(U,$J,358.3,8064,2)
 ;;=Dry Eye Syndrome^37168
 ;;^UTILITY(U,$J,358.3,8065,0)
 ;;=374.01^^53^570^20
 ;;^UTILITY(U,$J,358.3,8065,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8065,1,3,0)
 ;;=3^Entropion, Senile
 ;;^UTILITY(U,$J,358.3,8065,1,4,0)
 ;;=4^374.01
 ;;^UTILITY(U,$J,358.3,8065,2)
 ;;=Entropion, Senile^269074
 ;;^UTILITY(U,$J,358.3,8066,0)
 ;;=375.20^^53^570^68
 ;;^UTILITY(U,$J,358.3,8066,1,0)
 ;;=^358.31IA^4^2
